REX - REX American Resources Corporation
Jupiter Topco LLC purchased a new position in REX American Resources Corporation (NYSE: REX) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 49,840 shares of the energy company's stock, valued at approximately $2,248,000. Jupiter Topco LLC owned 0.15% of REX
REX American Resources Corporation (REX) Q2 2027 Earnings Call Transcript
REX American Resources NYSE: REX reported record second-quarter earnings per share for fiscal 2026, supported by stronger ethanol margins, improved product pricing and contributions from the Section 45Z production tax credit program.
DAYTON, Ohio--(BUSINESS WIRE)--REX American Resources Corporation (“REX” or the “Company”) (NYSE: REX), a leading ethanol production company, today announced financial and operational results for the Company's fiscal second quarter 2026. REX American Resources' fiscal second quarter 2026 results principally reflect its interests in six ethanol production facilities. The One Earth Energy, LLC (“One Earth”) and NuGen Energy, LLC (“NuGen”) ethanol production facilities are consolidated, while the.
Hsbc Holdings PLC bought a new stake in REX American Resources Corporation (NYSE: REX) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 16,459 shares of the energy company's stock, valued at approximately $746,000. Other hedge funds also recently
Connor Clark and Lunn Investment Management Ltd. bought a new position in REX American Resources Corporation (NYSE: REX) in the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought 33,618 shares of the energy company's stock, valued at approximately $1,518,000. Connor Clark and Lunn Investment Management Ltd.
On August 26, 2026, Bank of Montreal and REX Shares announced the launch of the MicroSectors™ 3× Long MANGOS+ ex Private Companies ETNs (MNGU), due July 31, 2046. Issued by BMO, it began trading today on the NYSE Arca, Inc.
On August 19, 2026, Bank of Montreal and REX Shares announced the launch of a new suite of exchange-traded notes (ETNs). These ETNs, issued by BMO, go live for trading on the Cboe BZX Exchange on Thursday, August 20, 2026.
REX American Resources remains rated “Hold” due to ongoing regulatory and industry volatility despite strong recent bottom-line performance and attractive current valuation. REX's profitability surged, with net income rising from $8.7 million to $18.5 million and adjusted operating cash flow reaching $20.3 million in Q1 2026, aided by tax credits and lower corn prices. Significant catalysts include the One Earth Energy expansion and carbon capture projects, but regulatory delays and ambiguous timelines limit near-term visibility and conviction.
REX American Resources Corporation (âREXâ or the âCompanyâ) (NYSE: REX), a leading ethanol production company, announced today that it will report its f
DAYTON, Ohio--(BUSINESS WIRE)--REX American Resources Corporation (“REX” or the “Company”) (NYSE: REX), a leading ethanol production company, announced today that it will report its fiscal second quarter 2026 operational and financial results on Wednesday, September 2nd, 2026 pre-market and will host a conference call and webcast at 11:00 a.m. ET that morning to review the results. To access the conference call, interested parties may dial (877) 269-7751 (US) or (201) 389-0908 (international).
Volatility from shifting Fed expectations and geopolitical events in today's current environment creates an ideal backdrop for active bond traders.
On August 4, REX Shares launched the Microsectors 3X Long Semiconductor ETN (SMHU) and the Microsectors -3X Short Semiconductor ETN (SMHD) on the Cboe BZX exchange. These ETNs provide leveraged exposure to the popular and strong performing VanEck Semiconductor ETF (SMH) by tracking the daily performance of the VettaFi Semiconductor Fund-Tracking Index (SEMIS).
On July 27, REX Shares filed for the REX Peptides ETF tracking the VettaFi Peptides Index. The fund targets companies strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products.
MIAMI--(BUSINESS WIRE)--T-REX, a joint venture between REX Shares ("REX") and Tuttle Capital Management ("TCM"), today announced the upcoming launch of the T-REX 2X Inverse DRAM Daily Target ETF (RAMZ), the first-ever -2x Inverse ETF in the U.S. tied to the Roundhill Memory ETF (Ticker: DRAM). The launch extends T-REX's record of first-to-market exposures, which includes the first 2x and -2x ETFs on Tesla (TSLT) and Nvidia (NVDX). RAMZ is expected to begin trading on July 28, 2026. The T-REX 2X.
Investor demand for AI chip manufacturers has surged this year. The industry is expected to reach revenues of $1.3 trillion in 2026, according to Yahoo Finance, driven by a global AI infrastructure buildout and a bottleneck for AI semiconductors and hardware.
MIAMI--(BUSINESS WIRE)--REX Shares ("REX") and Tuttle Capital Management ("TCM") today announce the launch of the T-REX 2X Long SKHY Daily Target ETF (NYSE Arca: HYNX), a leveraged ETF providing 2x daily long exposure to the SK hynix American Depositary Receipts (ADRs) (SKHY). HYNX is available in pre-market trading beginning at 4:00 a.m. ET. HYNX is designed to deliver 200% of the daily performance of the SK hynix ADRs (SKHY), before fees and expenses, giving traders a tool to engage with one.
According to ETF Database, the REX Drone ETF (DRNZ) fund attracted approximately $11.28 million in inflows during the first week of the month. An additional $4.6 million arrived on July 7, bringing its five-day net inflows to $15.88 million.
This ethanol and co-products supplier reported a notable insider sale amid a year of strong share price gains and steady sector demand.
SAN DIEGO, June 12, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced preclinical data for REX-8756, an oral, potent and selective STAT6 inhibitor, is being presented at two upcoming scientific congresses. At the European Association of Allergy and Clinical Immunology (EAACI) Congress taking place June 12-15, 2026, in Istanbul, Turkey, a poster will highlight data with REX-8756 from in vivo models of allergic asthma and dermatitis. At the Revolutionizing Atopic Dermatitis (RAD) Congress taking place June 17-19, 2026, in Nashville, TN, data from a preclinical model of atopic dermatitis and an in vivo pharmacokinetic and pharmacodynamic (PK/PD) model will be featured in a poster presentation.